卡前列素氨丁三醇市场 - 按应用（产后出血治疗、妊娠流产）、配销通路（医院药房、零售药房、线上药房） - 全球预测（2024 - 2032）

Carboprost Tromethamine Market - By Application (Postpartum Hemorrhage Treatment, Pregnancy Abortion), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Global Forecast (2024 - 2032)

出版日期: 2024年03月15日 | 出版商:

Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3个工作天内

价格

简介目录

由于产后出血(PPH) 和子宫收缩乏力等疾病的盛行率不断上升，特别是在发展中地区，卡前列素氨丁三醇市场预计从2024 年到2032 年将以7.9% 的复合年增长率增长。根据世界卫生组织的数据，每年约有 1,400 万名妇女遭受产后出血 (PPH)，导致全球约 7 万名孕产妇死亡。这些情况对分娩期间的孕产妇健康构成重大风险，需要采取有效的干预措施来控制出血并预防併发症。产科护理的进步以及医疗保健专业人员对管理 PPH 功效的认识不断提高，推动了卡前列素氨丁三醇在临床环境中的采用。

月经失调、不全流产等妇科疾病的治疗将进一步刺激市场扩张。随着医疗保健提供者寻求多种治疗方案来解决一系列生殖健康问题，对卡前列素氨丁三醇的需求正在上升。此外，有利的政府措施正在改善孕产妇保健基础设施并降低孕产妇死亡率，特别是在新兴经济体。

卡前列素氨丁三醇产业分为应用、配销通路和地区。

预计到2032 年，妊娠流产应用领域的市场份额将以8% 的复合年增长率增长。收缩并促进胎儿组织排出。随着药物流产作为外科手术的安全和非侵入性替代方案的接受度和可用性不断提高，对支持该过程的药物製剂的需求不断增长，这将促进该领域的增长。

根据配销通路，线上药局领域的卡前列素氨丁三醇市场价值预计在预测期内将增长 6.8%。线上药局提供的便利性和可及性使医疗保健提供者更容易购买卡前列素氨丁三醇等基本药物，特别是在传统实体药房访问有限的地区。线上药局提供多种药品，也使医疗保健专业人员能够方便地购买卡前列素氨丁三醇以及其他药物，以简化采购流程。

亚太地区卡前列素氨丁三醇产业规模将在2024年至2032年间显着扩张，复合年增长率为8.5%，原因是孕产妇死亡率高，特别是在产科护理机会有限的国家。药物流产手术的日益普及和生殖保健服务的普及导致产品需求不断增长。旨在改善孕产妇和生殖保健基础设施的政府支持性倡议，以及更高的医疗保健支出和意识，将进一步推动区域市场的成长。

产业生态系统分析
产业影响力
- 成长动力
  - 产后出血盛行率上升
  - 政府和各种组织的措施不断增加
  - 公共资助的计划生育服务不断增加
- 产业陷阱与挑战
  - 农村人口缺乏意识
  - 与使用避孕药物和装置相关的不良反应
成长潜力分析
监管环境
技术景观
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司市占率分析
竞争定位矩阵
战略展望矩阵

第 5 章：市场估计与预测：按应用分类，2018 - 2032

主要趋势
产后出血治疗
怀孕流产

第 6 章：市场估计与预测：按配销通路划分，2018 年 - 2032 年

主要趋势
医院药房
零售药局
网路药局

第 7 章：市场估计与预测：按地区划分，2018 年 - 2032 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 欧洲其他地区
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 沙乌地阿拉伯
- 南非
- 阿联酋
- 中东和非洲其他地区

第 8 章：公司简介

Advancion Corporation
Amneal Pharmaceuticals, Inc.
Apionex Pharma Pvt Ltd.
Biosynth Limited
Bio-Techne Corporation
BioSpectra Inc.
Dr. Reddy's Laboratories Ltd.
Merck & Co., Inc.
Monvi Laboratories Private Limited
Manus Aktteva Biopharma Llp
Pfizer Inc.
Ryvis Pharma Private Limited
SimSon Pharma Limited
Taj Pharmaceuticals Limited
The International Chemical Secretariat
Universal Biosensors, Inc.
Willis Towers Watson Public Limited Company
Woodward, Inc.

简介目录

Product Code: 8526

Carboprost tromethamine market is anticipated to grow at 7.9% CAGR from 2024 to 2032, driven by the increasing prevalence of conditions, such as postpartum hemorrhage (PPH) and uterine atony, particularly in developing regions. As per WHO, annually, around 14 million women endure postpartum hemorrhage (PPH), leading to roughly 70,000 maternal fatalities worldwide. These conditions pose significant risks to maternal health during childbirth, necessitating effective interventions to control bleeding and prevent complications. Advancements in obstetric care and rising awareness among healthcare professionals about the efficacy in managing PPH is fueling the adoption of carboprost tromethamine in clinical settings.

The treatment of gynecological disorders like menstrual disorders and incomplete abortion will further spur the market expansion. As healthcare providers seek versatile treatment options to address a range of reproductive health issues, the demand for carboprost tromethamine is rising. Furthermore, favorable government initiatives are improving maternal healthcare infrastructure and reducing maternal mortality rates, particularly in emerging economies.

The carboprost tromethamine industry is segmented into application, distribution channel and region.

The market share from pregnancy abortion application segment is anticipated to gain momentum and grow at 8%CAGR through 2032. Carboprost tromethamine is widely recognized as an effective uterotonic agent for inducing uterine contractions and facilitating the expulsion of fetal tissue during medical abortion procedures. With the increasing acceptance and availability of medical abortion as a safe and non-invasive alternative to surgical procedures, the growing demand for pharmacological agents to support the process will add to the segment growth.

As per distribution channel, the carboprost tromethamine market value from the online pharmacies segment is poised to witness 6.8% growth rate over the forecast period. The convenience and accessibility offered by online pharmacies makes it easier for healthcare providers to procure essential medications like carboprost tromethamine, particularly in regions with limited access to traditional brick-and-mortar pharmacies. The availability of a wide range of pharmaceutical products on online pharmacies also enables healthcare professionals to conveniently source carboprost tromethamine along with other medications for streamlining the procurement processes.

Asia Pacific carboprost tromethamine industry size will record notable expansion at 8.5% CAGR between 2024 and 2032, attributed to the high burden of maternal mortality rates, particularly in countries with limited access to obstetric care. The increasing adoption of medical abortion procedures and expanding access to reproductive healthcare services are contributing to the rising product demand. Supportive government initiatives aimed at improving maternal and reproductive healthcare infrastructure, along with higher healthcare expenditure and awareness will further fuel the regional market growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising prevalence of postpartum hemorrhage
  - 3.2.1.2 Increasing initiatives by government and various organizations
  - 3.2.1.3 Rising publicly funded family planning services
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Lack of awareness among rural population
  - 3.2.2.2 Adverse effects associated with use of contraceptive drugs and devices
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
- 3.6.1 Supplier power
- 3.6.2 Buyer power
- 3.6.3 Threat of new entrants
- 3.6.4 Threat of substitutes
- 3.6.5 Industry rivalry
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

5.1 Key trends
5.2 Postpartum hemorrhage treatment
5.3 Pregnancy abortion

Chapter 6 Market Estimates and Forecast, By Distribution Channel, 2018 - 2032 ($ Mn)

6.1 Key trends
6.2 Hospital pharmacies
6.3 Retail pharmacies
6.4 Online pharmacies

Chapter 7 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Rest of Europe
7.4 Asia Pacific
- 7.4.1 Japan
- 7.4.2 China
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 Saudi Arabia
- 7.6.2 South Africa
- 7.6.3 UAE
- 7.6.4 Rest of Middle East and Africa